Could a blood test replace the liver biopsy needle?

NCT ID NCT06819917

Recruiting now Diagnosis Sponsor: Roche Diagnostics GmbH Source: ClinicalTrials.gov ↗

First seen Feb 28, 2026 · Last updated May 15, 2026 · Updated 8 times

Summary

This study aims to find new blood-based markers that can accurately detect liver scarring (fibrosis) in people with fatty liver disease. Currently, the best way to check for scarring is a liver biopsy, which is painful and risky. Researchers will collect blood samples from 575 adults with suspected fatty liver disease and compare the results to their biopsy findings. The goal is to develop a simple, noninvasive test to diagnose liver fibrosis stage.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC FATTY LIVER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hvidovre Hospital
RECRUITING

Copenhagen, Denmark

Contact Email: •••••@•••••
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
RECRUITING

Mainz, Germany

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

NON-ALCOHOLIC FATTY LIVER NON-ALCOHOLIC FATTY LIVER DISEASE NON-ALCOHOLIC STEATOHEPATITIS NON-ALCOHOLIC STEATOHEPATITIS